Clinical trial · Observational
Role of Inflammatory Markers in Sepsis
Role of Inflammatory Markers Measured Using Flow Cytometry in the Diagnosis and Prognosis of Sepsis in Surgical Cancer Patients
NCT06111963CI-TRIAL-00092170completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A diagnostic and prognostic study, in which the expression of CD64 in activated neutrophils and CD64 and IL17A regulatory T cells in patients with sepsis will be evaluated as a probable marker for sepsis as a primary objective
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Diagnostic | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Serology tests | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Septic patients
- interventionNames
- Diagnostic Test: Serology tests
- label
- Non Septic patients
- interventionNames
- Diagnostic Test: Serology tests
Primary outcomes (3)
- measure
- To evaluate the expression CD4
- timeFrame
- 7 days
- description
- Serology
- measure
- To evaluate the expression CD25
- timeFrame
- 7 days
- description
- Serology
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Cancer patients admitted to the surgical ICU following cancer related surgeries and diagnosed with sepsis Exclusion Criteria: * Refusal of patient or patient guardian to participate. * Intraoperative massive blood loss and massive blood transfusion * Patients with impaired preoperative kidney or liver function tests
References
Publications (0)
Data not yet available
No reference posted for this study.